RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CTT Pharmaceutical Holdings Stock

CTT Pharmaceutical Holdings ROCE 2024

CTT Pharmaceutical Holdings ROCE

0

Ticker

CTTH

ISIN

US12651E1064

WKN

A14ZP5

In 2024, CTT Pharmaceutical Holdings's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.

CTT Pharmaceutical Holdings Aktienanalyse

What does CTT Pharmaceutical Holdings do?

CTT Pharmaceutical Holdings Inc. is a leading company in the pharmaceutical industry specializing in the development, manufacturing, and marketing of various cannabis-based products. It was founded in 2007 as a research company focused on the medical applications of cannabis. In 2014, the company received patents for their revolutionary platform technology for delivering cannabinoids through lozenges. CTT's business model is based on the development and commercialization of patented delivery systems for cannabinoids, primarily focusing on lozenges. It has subsidiaries and joint ventures in countries like the US, Mexico, and Australia. CTT aims to be a leading provider of cannabinoid-based medicines, with a focus on pain management, neurological disorders, and cancer treatment. Some of their key products include CannavertTM for chemotherapy-induced nausea and vomiting, OraldissTM for neurological conditions like epilepsy and Parkinson's disease, and AnesthevertTM for acute and chronic pain management. CTT collaborates with other pharmaceutical companies and research institutions to market their products and improve their technology. CTT Pharmaceutical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling CTT Pharmaceutical Holdings's Return on Capital Employed (ROCE)

CTT Pharmaceutical Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing CTT Pharmaceutical Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

CTT Pharmaceutical Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in CTT Pharmaceutical Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about CTT Pharmaceutical Holdings stock

What is the ROCE (Return on Capital Employed) of CTT Pharmaceutical Holdings this year?

The ROCE of CTT Pharmaceutical Holdings is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of CTT Pharmaceutical Holdings developed compared to the previous year?

The ROCE of CTT Pharmaceutical Holdings has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of CTT Pharmaceutical Holdings?

A high Return on Capital Employed (ROCE) indicates that CTT Pharmaceutical Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of CTT Pharmaceutical Holdings?

A low ROCE (Return on Capital Employed) can indicate that CTT Pharmaceutical Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from CTT Pharmaceutical Holdings impact the company?

An increase in the ROCE of CTT Pharmaceutical Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of CTT Pharmaceutical Holdings affect the company?

A decrease in ROCE of CTT Pharmaceutical Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of CTT Pharmaceutical Holdings?

Some factors that can affect CTT Pharmaceutical Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of CTT Pharmaceutical Holdings so important for investors?

The ROCE of CTT Pharmaceutical Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can CTT Pharmaceutical Holdings take to improve the ROCE?

To improve the ROCE, CTT Pharmaceutical Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does CTT Pharmaceutical Holdings pay?

Over the past 12 months, CTT Pharmaceutical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CTT Pharmaceutical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of CTT Pharmaceutical Holdings?

The current dividend yield of CTT Pharmaceutical Holdings is .

When does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings paid dividends every year for the past 0 years.

What is the dividend of CTT Pharmaceutical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CTT Pharmaceutical Holdings located?

CTT Pharmaceutical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von CTT Pharmaceutical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CTT Pharmaceutical Holdings from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did CTT Pharmaceutical Holdings pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of CTT Pharmaceutical Holdings in the year 2023?

In the year 2023, CTT Pharmaceutical Holdings distributed 0 USD as dividends.

In which currency does CTT Pharmaceutical Holdings pay out the dividend?

The dividends of CTT Pharmaceutical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CTT Pharmaceutical Holdings

Our stock analysis for CTT Pharmaceutical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTT Pharmaceutical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.